(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

Clinical trial NCT05923502 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05923502
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Follicular Lymphoma Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Richter Syndrome Marginal Zone Lymphoma Peripheral T Cell Lymphoma Diffuse Large B Cell Lymphoma

Start date: 2023-10-20
Primary completion: 2027-11-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.